President Donald Trump announced Friday that the FDA has approved the experimental drug remdesivir for emergency use in hospitalized coronavirus patients. It is the first drug shown to help fight the disease, which has killed more than 64,000 people in the United States. Gilead’s chief executive officer Daniel O’Day, whose company produces remdesivir joined President Trump, … Read more
On the heels of an early announcement that coronavirus patients given Gilead’s Ebola drug remdesivir fared better than those who didn’t get the treatment, the company’s CEO, Daniel O’Day, deemed the results a cause for ‘hope at a time when it is badly needed,’ in an open letter obtained by Fox News. ‘Positive data’ from … Read more
The US may approve emergency use of an Ebola drug today after one Oxford academic hailed its trial as a ‘fantastic result’ in the fight against COVID-19. Remdesivir, an antiviral made by California-based Gilead Sciences, was shown to slash recovery times in a global trial of more than 1,000 patients, including Britons. Anthony Fauci, America’s top … Read more
The US may approve emergency use of an Ebola drug today after one Oxford academic hailed its trial as a ‘fantastic result’ in the fight against COVID-19. Remdesivir, an antiviral made by California-based Gilead Sciences, was shown to slash recovery times in a global trial of more than 1,000 patients, including Britons. Anthony Fauci, America’s top … Read more
The US Food and Drug Administration (FDA) may announce its decision allowing emergency use authorization of an antiviral drug to treat coronavirus patients as early as Wednesday. It comes after studies showed that remdesivir, made by California-based Gilead Sciences, helped patients go from relying on oxygen to leaving hospital in two weeks, reported The New … Read more
The US Food and Drug Administration (FDA) may announce its decision allowing emergency use authorization of an antiviral drug to treat coronavirus patients as early as Wednesday. It comes after studies showed that remdesivir, made by California-based Gilead Sciences, helped patients go from relying on oxygen to leaving hospital in two weeks, reported The New … Read more
More than half of severely ill coronavirus patients treated with Ebola drug remdesivir recovered and were discharged from hospital within two weeks, trial results reveal Gilead Sciences treated 200 severely ill coronavirus patients with its Ebola antiviral remdesivir Regardless of whether they were treated for five or 10 days, more than half of the patients … Read more
The first results from an international experimental US antiviral drug are promising, even as a trial of the same drug in China shuts down. More than half of a group of severely ill coronavirus patients from the US, Canada, Europe and Japan improved after taking remdesivir made by California-based Gilead Sciences. Originally developed as a … Read more
Fresh hope for coronavirus treatment as anti-Ebola drug shows early signs it may be effective in fighting Covid-19 Gilead Sciences’ drug remdesivir was originally developed for Ebola crisis Has been tested on a trial group of 53 severely ill coronavirus patients Scientists say the condition of more than half improved but seven patients died However there was no … Read more
Gorillas in Rwanda, Uganda and the Democratic Republic of Congo have been ‘put on lockdown’ amid fears that they might also be able to catch the coronavirus. The move has seen gorilla tourism suspended for present and the closure of sanctuaries for other apes — including orangutans, which are also endangered. While habitat loss and … Read more